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Available online 16 December 2013Abstract The Wnt gene family consists of structurally related genes encoding secreted signaling molecules that have been
implicated in many developmental processes, including regulation of cell fate and patterning during embryogenesis. Previously,
we found that Wnt signaling is required for primitive or yolk sac-derived-erythropoiesis using the murine embryonic stem cell (ESC)
system. Here, we examine the effect of Wnt signaling on the formation of early hematopoietic progenitors derived from human
ESCs. The first hematopoietic progenitor cells in the human ESC system express the pan-hematopoietic marker CD41 and the
erythrocyte marker, glycophorin A or CD235. We have developed a novel serum-free, feeder-free, adherent differentiation system
that can efficiently generate large numbers of CD41 + CD235+ cells. We demonstrate that this cell population contains progenitors
not just for primitive erythroid and megakaryocyte cells but for the myeloid lineage as well and term this population the primitive
common myeloid progenitor (CMP). Treatment of mesoderm-specified cells with Wnt3a led to a loss of hematopoietic colony-
forming ability while the inhibition of canonical Wnt signaling with DKK1 led to an increase in the number of primitive CMPs.
Canonical Wnt signaling also inhibits the expansion and/or survival of primitive erythrocytes and megakaryocytes, but not myeloid
cells, derived from this progenitor population. These findings are in contrast to the role of Wnt signaling during mouse ESC
differentiation and demonstrate the importance of the human ESC system in studying species-specific differences in development.
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442 P. Paluru et al.IntroductionEmbryology has offered important insights into key path-
ways regulating embryonic stem cell (ESC) differentiation
and efficient induction of endoderm, mesoderm, and ecto-
derm (reviewed in (Gadue et al., 2005; Loebel et al., 2003)).
By modulating developmentally important signaling pathways,
it is possible to mimic the process of embryogenesis to drive
the differentiation of stem cells through discreet developmen-
tal intermediaries (Murry and Keller, 2008). The Wnt pathway
has been shown to be especially important in regulating
multiple stages of development of hematopoietic cells from
pluripotent stem cells (PSCs) including mesoderm formation
and hematopoietic specification in both mice and humans
(Gadue et al., 2006) (Gertow et al., 2013; Hwang et al., 2009;
Lengerke et al., 2008; Lindsley et al., 2006; Nostro et al., 2008;
Vijayaragavan et al., 2009; Woll et al., 2008).
The Wnt pathway is evolutionary conserved and diversifies
into two main branches, canonical (β-catenin-dependent) and
non-canonical (β-catenin-independent) (reviewed in (Wodarz
and Nusse, 1998)). Both branches play critical roles in specifying
cellular fate andmovement during embryonic development and
adult tissue regeneration. Activation of the canonical Wnt
signaling pathway occurs through ligand binding of Wnts to a
Frizzled family receptor that is associated with a co-receptor
belonging to the LRP-5/6/arrow family. This activation inhibits
the destruction complex, APC/Axin/CK1/GSK3β, leading to the
stabilization of β-catenin and its translocation to the nucleus
where it interacts with TCF/LEF family transcription factors
(reviewed in (Logan and Nusse, 2004)). The secreted antago-
nists, sFRPs, WIF-1, and DKKs, can inhibit this pathway by
blocking receptor binding. In the absence of a Wnt ligand,
GSK3β in the destruction complex phosphorylates β-catenin,
which marks it for degradation. The non-canonical Wnt sig-
naling pathways appear to function in a β-catenin indepen-
dent manner, designated as Wnt/Calcium and Wnt/JNK in
vertebrates and Wnt/planar cell polarity pathway and does
not utilize the LRP co-receptors (reviewed in (Veeman et al.,
2003)).
While there is consensus that Wnt signaling plays im-
portant roles in hematopoietic development from PSCs,
there is conflicting data especially on the role of canonical
Wnt signaling in hematopoietic specification or survival. We
have previously shown that activation of the Wnt pathway in
murine ESC-derived hematopoiesis is essential for estab-
lishment of the primitive erythroid, but not definitive,
lineages (Nostro et al., 2008). These data are supported by a
publication examining human ESC-derived hematopoiesis
suggesting that the canonical Wnt family member, Wnt3a,
functions by expanding ESC-derived hematopoietic progenitors
(Vijayaragavan et al., 2009). In contrast, a study by Gertow et
al. demonstrates that canonical Wnt signaling is inhibitory for
hematopoietic colony formation from human ESCs (Gertow et
al., 2013). To address these seemingly contradictory results,
the role of Wnt signaling in the specification and expansion of
hematopoietic cells derived from human ESCs was examined.
For differentiating PSCs into hematopoietic progenitor cells,
we developed a novel 2-dimensional system that avoids the use
of feeder cells, serum or embryoid body (EB) formation. We
show that the earliest population of hematopoietic progenitor
cells have erythroid, megakaryocyte, and myeloid potentials.The first hematopoietic cells co-express CD41 and CD235,
typical markers of megakaryocyte and erythrocyte progenitors,
respectively. By using this system, we examined the effect of
Wnt signaling at various stages of hematopoietic development
of human ESCs. Unlike the murine system, we found that
canonical Wnt signaling inhibits the development and expan-
sion of this progenitor population. This inhibitory effect also
impacts the expansion of erythrocytes and megakaryocytes,
but not the myeloid lineage. These studies highlight the im-
portance of working with human ESCs as species-specific
differences can be addressed when translating findings from
the murine system.
Materials and methods
Human ESC line maintenance
The human ESC line used in this study was H9 (NIH code WA09
from Wicell Research Institute, Madison, WI) and the iPS cell
line, CHOPWT2.2, has been described previously (Mills et al.,
2013). Minor modifications weremade to the basic protocols for
growth and maintenance of human ESC lines that have been
previously described (Amit et al., 2000). Briefly, cells were
grown on irradiated mouse embryonic feeder cells in mainte-
nance medium consisting of DMEM/F12 supplemented with a
20% knock-out serum replacement, 100 μM non-essential amino
acids, 0.075% sodium bicarbonate, 1 mM sodium pyruvate,
2 mM glutamine, 50 U/ml penicillin, 50 g/ml streptomycin (all
from Invitrogen, Grand Island, NY), 10−4 M β-mercaptoethanol
(Sigma, St Louis, MO), and 10 ng/ml human bFGF (Stemgent) in
6-well tissue culture plates at 37 °C, 5% CO2 and atmospheric
O2. The medium was changed daily or every 2 days and
colonies were typically passaged every week following size
and morphology assessment. Cells were passaged to new
feeders as small clusters in human ESC medium containing
ROCK inhibitor (10 μM) using TrypLE (Invitrogen) and gentle
scraping using a 25 cm, 2-position blade cell scraper (Sarstedt,
Newton, NC). The enhanced green fluorescent protein (GFP)
expressing H9 sub-line was generated using a previously
published strategy to target the construct into the AAVS1
locuswith a zinc finger nuclease (Hockemeyer et al., 2009). The
construct contained a chicken actin promoter which drives the
expression of GFP.
Differentiation of human ESCs
Prior to the induction of differentiation, cells (2–4 × 105/well)
were feeder depleted by culturing on Matrigel coated wells (BD
Biosciences, Bedford, MA) (6-well tissue culture plate, Falcon
3046) in human ESCmaintenancemedium for 24 to 48 h or until
the cells reached ~70% confluence. When the cells were ready
for differentiation, one well of cells was used for cell count and
pluripotency assessment by analysis of the surface markers,
SSEA3 and SSEA4 (N90% co-expression). Three different base
media were used in the differentiation protocol and all were
supplemented with 2 mM glutamine, 50 μg/ml ascorbic acid
(Sigma, St. Louis, MO), 150 μg/ml transferrin (Roche Diagnos-
tics), and 4 × 10−4 Mmonothioglycerol (MTG) (Sigma). The base
media were RPMI (Invitrogen), StemPro-34 (SP-34) (Invitrogen),
and serum free differentiation (SFD) media (Gadue et
al., 2006). The cultures were maintained at 37 °C in an
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cytokines that were used each day of differentiation are as
follows: Days 0–1 RPMI with 5 ng/ml BMP4, 50 ng/ml VEGF
and 25 ng/mlWnt3a; Day 2 RPMI with 5 ng/ml BMP4, 50 ng/ml
VEGF and 20 ng/ml bFGF; Day 3 SP34 with 5 ng/ml BMP4,
50 ng/ml VEGF and 20 ng/ml bFGF; Days 4–5 SP34 with
15 ng/ml VEGF and 5 ng/ml bFGF; Day 6 SFD with 50 ng/ml
VEGF, 100 ng/ml bFGF, 100 ng/ml SCF, and 25 ng/ml Flt3L;
Days 7–9 SFD with 50 ng/ml VEGF, 100 ng/ml bFGF, 100 ng/ml
SCF, 25 ng/ml Flt3L, 50 ng/ml TPO, 10 ng/ml IL-6, and 0.05–
2 U EPO. Fresh media mixes (2 ml/well) were added each day.
Extensive cell death occurred up to day 2 of differentiation
followed by the formation of a monolayer of cells. By day 6,
cellular proliferation was apparent and the volume of medium
was increased to 4 ml/well. From days 7 to 9, single cells shed
off of the adherent layer into the medium and were collected
for further analysis. During differentiation, cells in the adherent
layer were analyzed for surface markers by dissociation into
single cells using 0.25% trypsin-EDTA (1 ml/well, 5 min at room
temperature). MouseWnt3a 50 ng/ml, mouseWnt5a 50 ng/ml,
human DKK1 150 ng/ml, and CHIR99021 1 μM were added to
differentiation cultures as time points indicated in the text. In
Fig. 4, the day 9 sorted cells were cultured in SFD media
containing 50 ng/ml VEGF, 100 ng/ml bFGF, 100 ng/ml SCF,
25 ng/ml Flt3L, 50 ng/ml TPO, 10 ng/ml IL-6, 10 ng/ml IL3,
and 0.05 U EPO. In Fig. 5, sortedmegakaryocytes were cultured
in 50 ng/ml TPO and 25 ng/ml SCF, sorted erythroid cells
were cultured in 2 U EPO and 25 ng/ml SCF, and sorted
myeloid cells were cultured in 10 ng/ml IL-3 and 25 ng/ml
SCF. The neutrophil expansionmedia was as described in (Choi
et al., 2011) and included 3 days of culture with 200 ng/ml
GM-SCF followed by an additional two days of culture in
100 ng/ml G-CSF on an OP9 feeder layer. Primitive CMPs were
cryopreserved in an ice cold serum mixture (90% FBS + 10%
DMSO) and slowly frozen in a styrofoam box at −80 °C.
Flow cytometry, cell sorting, and colony assays
Analysis of the cells was performed using a Cantos flow
cytometer (Becton Dickinson, San Jose, CA). Cell sorting
was performed using a FACS Aria II (Becton Dickinson).
Flow cytometric data were analyzed using the FlowJo
(Treestar, San Carlos, CA) software program. The antibodies
used in this study-included anti-KDR-PE (R&D Systems), anti-
CD235-APC, anti-CD31-PE-Cy7, anti-CD43-FITC, anti-CD41a-PE,
anti-CD42a-PE, anti-CD18-APC, anti-CD71-PE, and anti-CD45-
pacific blue (BD Pharmingen). The analysis of hematopoietic
progenitor cells was performed using methylcellulose (Stem
Cell Technologies H4230) supplemented with the cytokines
interleukin-3 (IL-3), erythropoietin (EPO), GM-CSF, and stem
cell factor (SCF) permanufacturer's instructions. The analysis
of megakaryocyte progenitor cells was performed using
Megacult (Stem Cell Technologies 04900) supplemented
with the cytokines thrombopoietin (TPO), IL-3, and
interleukin-6 (IL-6), as per the manufacturer's instructions.
RT-PCR and quantitative real-time PCR
Total RNA was prepared using the RNeasy mini or micro
kits (Qiagen, Valencia, CA) in which samples were treated
with RNase-free DNase. The reverse transcription of RNA(100 ng-1 μg) into cDNA was performed using random
hexamers with Superscript II reverse transcriptase (RT)
(Life technologies, Grand Island, NY), according to the
manufacturer's instructions. Real-time quantitative polymerase
chain reaction (PCR) was performed on the LightCycler-480
(Roche-Genentech, South San Francisco, CA). All the experi-
ments were done in triplicate with SYBR-GreenER pPCR
SuperMix (Life technologies, Grand Island, NY), according to
the manufacturer's instructions. Primers for all the genes
(Supplemental Table 1) were prepared by Integrated DNA
Technologies, Inc. (www.idtdna.com). Dilutions of human
genomic DNA standards ranging from 100 ng/μl to 50 pg/μl
were used to evaluate PCR efficiency of each gene relative to
the housekeeping gene Cyclophilin.
Results
Generation of a single population of
hematopoietic progenitors
To differentiate human ESC and iPSCs to hematopoietic
lineages, a number of assays have been developed that utilize
either EB formation (Kennedy et al., 2007; Ng et al., 2005;
Zambidis et al., 2005) or cell culture in the presence of
stromal cell lines (Kaufman et al., 2001; Vodyanik et al.,
2005). We developed a serum and stromal-free cell differen-
tiation protocol using adherent conditions in which a homog-
enous population of non-adherent hematopoietic progenitor
cells is produced (see Materials and methods). This system is
designed to follow distinct stages of development including
the induction of primitive streak (PS) formation and specifi-
cation ofmesoderm followed by thematuration and expansion
of hematopoietic progenitor cells (Fig. 1A). The induction
and specification phases of the protocol involve the plating
of undifferentiated ESCs onto Matrigel in the presence of
BMP4 and Wnt3a, conditions that lead to efficient meso-
derm development (Fig. 1A). The cells are then cultured in
VEGF and bFGF to expand the hematopoietic mesoderm
population and subsequently in a combination of bFGF, VEGF,
SCF, and Flt3L to expand the hematopoietic progenitors. As an
indicator of mesoderm differentiation, possibly hemogenic
endothelium, the co-expression of KDR and CD31 on the total
adherent cell population was analyzed by flow cytometry.
Fig. 1A shows that approximately 50% of the cells co-expressed
these surface markers by day 4. From days 7–9 of differenti-
ation, non-adherent cells began appearing in the culture
supernatants. Approximately 90% of these cells expressed
CD43 (data not shown), a marker of early hematopoietic
progenitors (Vodyanik et al., 2006), and co-expressed CD41
and CD235 (Fig. 1B); markers that have been used to define a
megakaryocyte-erythroid progenitor (MEP) derived from
human ESCs (Klimchenko et al., 2009; Vodyanik et al., 2006).
To characterize the progenitor potential of these MEP-like
cells, gene expression and colony assays were performed. The
hematopoietic genes RUNX1 (Kumano and Kurokawa, 2010)
and SCL (Lécuyer and Hoang, 2004) were expressed in
non-adherent cells collected from days 7–9 and GATA1
(Crispino, 2005) was expressed in cells collected at days 8
and 9 (Fig. 1C). The red cell transcription factor EKLF (Yien and
Bieker, 2013) was highly expressed in cells collected on day 9 of
differentiation. These data correlated with the potential of
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Figure 1 Monolayer differentiation of human ESCs generates multipotent hematopoietic progenitors. (A) Representative flow
cytometric analyses of ES cells (SSEA4 vs. SSEA3), day 5 hemogenic mesoderm (CD31 vs. KDR) and day 9 hematopoietic progenitors (CD235
vs. CD41) induced in a serum free/feeder free adherent culture system. (B) Flow cytometric analysis of CD235 vs. CD41 expression on the
non-adherent population obtained from days 7, 8 and 9 of the adherent differentiation cultures. (C) QRT-PCR gene expression analyses of
ES cells and the day 7, 8, and 9 non-adherent cells shown in B. (D) Day 7, 8 or 9 non-adherent cells shown in B were assayed for progenitor
colony forming potential and myeloid, mixed (muti-potential) and erythroid colonies were quantified. (E) Cytospins showing
May-Grünwald Giemsa staining of myeloid, erythroid and mixed colonies. Scale bars represent 20 μm. Arrows in the myeloid cytospin
indicate cells with neutrophil morphology. (F) Non-adherent cells from H9 and H9-GFP ESC lines at days 7, 8 and 9 of differentiation were
mixed at a 1:1 ratio and plated in a methylcellulose colony assay. Mixed colonies were scored based upon GFP expression (GFP+: all cells
in a colony GFP positive, GFP−: all cells in a colony GFP negative, GFP+/−: mixture of GFP positive and negative cells in a colony). Scale
bars represent 500 μm.
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445The negative impact of Wnt signaling on megakaryocyte and primitive erythroid progenitorsthese cells to generate erythroid colonies, which increased
at each time point and was maximal at day 9 of differen-
tiation (Fig. 1D). We also tested the expression of globin
chains in colonies picked from methycellulose and from
CD41 + CD235+ cells at days 7, 8, and 9 of differentiation
(Supplemental Fig. 1). We found mainly expression of
epsilon globin, with little gamma globin and no beta globin
expression, indicative of primitive erythrocytes. Of interest
was the observation that mixed and myeloid colonies were
also generated from cells taken at each time point. The
myeloid colony count remained constant while the mixed
colony count gradually decreased at the later time points.
Cytospins of each colony type showed primitive erythrocyte
cells in erythroid colonies; monocyte/macrophages and neu-
trophils in the myeloid colonies; and macrophage, primitive
erythrocytes, and megakaryocytes in the mixed colonies
(Fig. 1E). To confirm the neutrophil forming ability of the
CD41 + CD235+ population, we expanded these cells for five
days in neutrophil inducing conditions (Choi et al., 2011)
(Supplemental Fig. 2) and demonstrate robust co-expression of
CD15 and CD66b along with distinct neutrophil morphology as
demonstrated by cytospin.
The presence of mixed and myeloid colonies from the
CD41 + CD235+ MEP-like population of cells was somewhat
unexpected because previous studies have suggested that
these cells are restricted in progenitor potential to the
erythroid and megakaryocyte lineages only (Klimchenko et
al., 2009; Vodyanik et al., 2006). To confirm that the mixed
colonies were clonal in nature, mixing experiments were
performed using normal H9 human ESCs and a sub-line that
constitutively expresses GFP (see Materials and methods).
Non-adherent cells from days 7–9 of differentiation were
mixed 1:1 and plated in colony assays (Fig. 1F). The numbers
of mixed colonies that were GFP+, GFP−, or containing a
mixture of GFP+ and GFP− cells were counted at each time
point. Only GFP+ or GFP- mixed colonies were present from
all time points examined with a complete absence of
GFP+/− colonies demonstrating that the mixed colonies
were derived from a single cell. The colony numbers were
greatest from the day 7 progenitors and decreased with
cells from later time points. These data demonstrate that
the CD41 + CD235+ cells generated using our adherent
differentiation protocol have multipotent progenitor activ-
ity. These cells will be designated as primitive common
myeloid progenitors (CMPs) instead of MEPs in the remain-
der of this manuscript.
One advantage of this differentiation system is that it
enables purification of primitive CMPs by simply harvest-
ing the CD41 + CD235+ non-adherent progenitor cells in
the culture supernatant. These CMPs can then be analyzed
in downstream assays including colony assays (Fig. 1D). Im-
portantly, this CMP population can be cryopreserved with 80%
viability after 6 months and 70% viability after one year
(Supplemental Fig. 3A). These cryopreserved cells can be
induced to differentiate into myeloid, erythroid, and mega-
karyocytes in liquid expansion media and perform in colony
assays with similar efficiency to non-cryopreserved cells
(Supplemental Figs. 3B and C). The advantage of being able
to cryopreserve CMPs is that stocks of progenitors can be
collected to use at later time points without the need to
perform laborious and time-consuming in vitro differentiation
assays for downstream analyses.Inhibition of human ESC-derived primitive CMPs
by Wnt3a
We have previously demonstrated the absolute requirement
of the Wnt signaling pathway in murine primitive erythro-
poiesis during the in vitro differentiation of mouse ES cells
(Nostro et al., 2008). To examine the role of this pathway in
human primitive hematopoiesis, Wnt3a was added to the
differentiation cultures starting at day 4 of differentiation.
This time point was selected because typically ~50% of the
cells were KDR + CD31+ (Fig. 1A), indicative of mesoderm
specification; and are negative for CD43, CD235, and CD41
(data not shown); suggesting that hematopoietic lineage
specification had not yet occurred. The non-adherent cells
generated in the differentiation cultures at day 9were analyzed
for surface markers, gene expression, and progenitor potential.
One of the first observations was that the day 9 primitive CMP
population in the presence of Wnt3a was greatly reduced with
only ~5% of the non-adherent cells expressing CD41 + CD235+
(Fig. 2A). In addition, the absolute number of non-adherent
cells was decreased by over 10-fold with Wnt3a treatment
(Fig. 2B, right), leading to a N200-fold decrease in primitive
CMPs. To more precisely determine the timing of the Wnt
mediated inhibition, we added Wnt3a for a single 24 hour
period starting at day 3, prior to the expression of CD31 but
after KDR up-regulation (Supplemental Fig. 4A). We found that
treatment even at this early stage inhibited the generation of
CD41 + CD235+ cells, though to a slightly lessor degree than
when given at day 4 (Supplemental Figs. 4B and C). To confirm
that this finding was due to Wnt signaling, the Wnt antagonist
DKK1 (Glinka et al., 1998) was added to the cultures also
starting at day 4 of differentiation. The addition of DKK1 had
little impact on the percentage of CD41 + CD235+ cells in the
non-adherent population but resulted in a 2–3-fold increase in
the number of total non-adherent cells (Figs. 2A and B). Cell
numbers in the adherent layer demonstrated a mild effect of
either Wnt3a or DKK1 treatment (Fig. 2B, left), suggesting that
these effects were not due to general toxicity. To ensure that
DKK1 treatment only affected the number of progenitors but
not their developmental potential, gene expression analyses
and colony assays were performed. The expression of hemato-
poietic and lineage-specific genes; EKLF,GATA1, PF4 and cFMS;
and the numbers of myeloid, mixed, erythroid, and megakar-
yocyte colonies were comparable between DKK1-treated and
control cells (Figs. 2C and D). In addition, the few non-adherent
cells generated in the Wnt3a treated samples failed to form
hematopoietic colonies (Fig. 2D). Similar results were found
with a wild-type human iPS cell line, where Wnt3a addition led
to a loss of CD41 + CD235+ cells and hematopoietic colony
forming ability while DKK1 treatment increased the number of
these cells (Supplemental Figs. 5A, B and C). These studies
demonstrate that Wnt signaling is inhibitory to the generation
of the primitive CMP population derived from human PSCs.
Because Wnt3a had such a dramatic effect on the number
of primitive CMPs, we further examined the contributions of
canonical and non-canonical Wnt signaling in this develop-
mental pathway. To activate the canonical Wnt pathway
directly and bypass the receptor, a small molecule inhibitor
of GSK3β (GSK), CHIR99021 (Murray et al., 2004), was used.
To activate the non-canonical pathway, Wnt5a was used. To
inhibit both pathways, a soluble inhibitor of Wnt, sFRP1, was
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Figure 2 Wnt signaling is inhibitory to the generation of CD235 + CD41+ early hematopoietic progenitors from human ESCs. (A) Flow
cytometric analyses of CD235 vs. CD41 on day 9 non-adherent cells treated with DKK1 (Dkk) or Wnt3a starting on day 4 of differentiation.
(B) Cell yields from the entire culture (adherent and non-adherent cells) or non-adherent cells treated as described in A. (C) QRT-PCR
gene expression analyses of lineage specific genes in control and DKK1 treated cells. (D) Day 9 non-adherent cells treated as described in A
assayed for progenitor potential in methylcellulose and Mega-cult colony assays.
446 P. Paluru et al.employed (Yamamoto et al., 2008). Cells were treated at
day 4 of differentiation with these various agents and the
non-adherent cells at day 9 of differentiation were analyzedfor CD41 and CD235 expression (Fig. 3A). Approximately 80%
of the non-adherent cells were CD41 + CD235+ in the
cultures treated with both Wnt5a and sFRP1 while b5% were
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Figure 3 Canonical Wnt signaling inhibits hematopoiesis. (A) Flow cytometric analyses of CD235 vs. CD41 on day 9 non-adherent
cells treated starting on day 4 of differentiation with sFRP1, Wnt5a, GSK3β inhibitor (GSK), and GSK3β inhibitor + Wnt5a. (B) Cell
yields for the entire culture (adherent and non-adherent) and non-adherent cells treated as described in A. (C) QRT-PCR expression
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447The negative impact of Wnt signaling on megakaryocyte and primitive erythroid progenitorsCD41 + CD235+ in the cultures treated with the GSK inhibitor
alone or in combination with Wnt5a. Wnt5a and sFRP1 both
increased the number of non-adherent cells in a manner
similar to DKK1 treatment, suggesting a possible role of
non-canonical Wnt signaling in this developmental stage
(Fig. 3B). GSK inhibitor treatment led to a drastic decrease
in the number of non-adherent cells both alone and in
combination with Wnt5a. Because the GSK inhibitor was
dominant over Wnt5a, these data suggest that enhanced CMP
generation induced by Wnt5a may have been due to inhibition
of the canonical pathway. Gene expression studies show that
the CD41 + CD235+ cells generated following treatment with
sFRP1 and Wnt5a were comparable to the untreated control
population of cells (Fig. 3C). These data suggest that the
canonical Wnt pathway inhibits the production of the primitive
CMP population of cells.Inhibition of lineage maturation by Wnt3a
Because Wnt3a had such a profound effect on the generation
of primitive CMPs, the effect of Wnt3a on CMP-derived
lineage maturation was examined. To ensure purity of the
starting CMP population, day 9 CD235 + CD41+ cells weresorted (Fig. 4A, left). The sorted cells were expanded for one
week in culture with a mixture of cytokines to generate
erythroid, megakaryocyte, and myeloid lineages in the pres-
ence or absence ofWnt3a or DKK1. The addition ofWnt3a led to
a decrease in cell number with a complete loss of cells after one
week in culture (Fig. 4B). The addition of DKK1 to the liquid
cultures did not statistically affect either cell expansion or the
proportions of megakaryocyte, erythroid or myeloid cell
generation. The DKK1-treated and control cells also had similar
gene expression and progenitor profiles (Figs. 4C and D). The
addition of Wnt3a directly into the methylcellulose in colony
forming assays led to a drastic decrease in mixed, erythroid and
megakaryocyte colony production with a smaller effect on
myeloid colony production while DKK1 treatment had no effect
(Fig. 4D). These data suggest that Wnt3a signaling acts on
primitive CMP cells and causes cell death and/or impaired cell
proliferation.
To address the question of whether Wnt signaling affects
the committed primitive CMP-derived hematopoietic line-
ages, megakaryocytes, erythrocytes, and myeloid cells were
generated from primitive CMPs, purified by cell sorting and
cultured in the presence or absence of Wnt3a or DKK1 (Fig. 5).
Cell counts and cell surface marker analyses were performed.
The erythroid and megakaryocyte lineages remained sensitive
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Figure 4 Wnt signaling inhibits the expansion or survival of CD235 + CD41+ CMPs. (A) The left flow cytometric profile shows sorted day
9 CD235 + CD41+ H9-derived CMPs. The right profiles show these cells cultured for 7 days in hematopoietic cytokines ± DKK1 (Dkk) and
analyzed for markers of megakaryocytes (CD41 vs. CD42), erythrocytes (CD41 vs. CD235), and myeloid cells (CD45 vs. CD18). (B) Cell
counts of the cells treated as described in A at days 9, 13 and 16 compared to the untreated (Control) cells. (C) QRT-PCR expression
analyses of lineage specific genes in day 4 mesoderm, day 9 sorted CD235 + CD41+ cells, and cells treated with DKK1/Wnt3a as described
in A. (D) Sorted day 9 CD235 + CD41+ cells as described in A plated inmethylcellulose and Mega-cult based colony assays with the addition
of DKK1 (Dkk) or Wnt3a.
448 P. Paluru et al.to the effects of Wnt3a as shown by a steady decrease in
percentage and absolute numbers of cells compared to the
untreated control cultures (Figs. 5B and C). Themyeloid lineage
was not affected by the presence of Wnt3a (Fig. 5B and C).DKK1 treatment had no effect on any of these lineages. Taken
together, these data suggest that canonical Wnt signaling acts
to disrupt primitive CMP generation and expansion or survival of
megakaryocytes and erythrocytes derived from primitive CMPs.
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Figure 5 Wnt signaling affects megakaryocyte and erythroid survival/expansion. (A) Flow cytometric profiles of sorted
megakaryocyte (CD41 + CD42 +), erythroid (CD41 − CD235+), and myeloid (CD45 + CD18+) cells. (B) Sorted cells from A were
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vs. CD71, and CD18 vs. CD45. (C) Cell counts of two time points for cultures treated as described in B.
449The negative impact of Wnt signaling on megakaryocyte and primitive erythroid progenitorsDiscussionThe first hematopoietic progenitor population derived from
the in vitro differentiation of human pluripotent stem cells
expresses the cell surface antigens CD41 and CD235 and has
been described to have primitive erythroid and megakaryo-
cyte potential (Klimchenko et al., 2009; Vodyanik et al.,
2006). In our culture system, this population of cells is
comprised of tri-potent progenitors for the erythroid, mega-
karyocyte, and myeloid lineages. We demonstrate that overtime in the differentiation cultures the colony forming potential
of the CD41 + CD235+ population changes, with an increase in
erythroid potential and a loss of mixed colony forming potential
while maintaining expression of the CD41 and CD235 cell
surface markers (Fig. 1). These data suggest kinetic changes in
the developmental potential of the CD41 + CD235+ population
over time andmay explain apparent discrepancies between our
work and previously published reports. It will be critical in the
future to establish additional markers that correlate more
closely with lineage specification. While the generation of a
human primitive CMP population described here is novel, it is
450 P. Paluru et al.not necessarily unexpected from our understanding of yolk sac
hematopoiesis in themouse system. A bi-potent population that
generates primitive erythrocytes and megakaryocytes has been
isolated from the early yolk sac and termed the primitive MEP
(Tober et al., 2007). But it has been well established that
primitive erythroid, megakaryocyte, and myeloid lineage
progenitors are all present in the early mouse yolk sac, prior
to circulation (Palis et al., 1999; Xu et al., 2001). Therefore,
it is possible that a tri-potent primitive CMP population is
also present in the early mouse embryo. Further experi-
mentation is needed to determine whether this is the case
or human primitive hematopoiesis is divergent from themouse.
Species-specific differences in primitive hematopoiesis have
been described. For example, zebrafish primitive erythrocytes
andmyeloid cells are derived fromdistinct anatomical locations
(Chen and Zon, 2009).
Here, we show a dramatic inhibitory effect of canonical
Wnt signaling on the development and/or survival of human
primitive CMP and CMP-derived erythrocytes and megakar-
yocytes. This is in stark contrast to the murine system where
we demonstrated that Wnt signaling enhanced primitive
erythrocyte development (Nostro et al., 2008). Gertow et al.
also demonstrated that the addition of Wnt3a into colony
forming assays of human ES cells suppressed the generation
of both blast and hematopoietic colonies (Gertow et al.,
2013). These findings suggest that there are species specific
differential requirements for Wnt signaling in early hemato-
poiesis. Our work extends the findings of Gertow et al. by
demonstrating an inhibitory effect of Wnt on the survival or
expansion of purified erythrocytes andmegakaryocytes derived
from primitive CMPs.
Wnt signaling has been previously studied during hemato-
poietic differentiation from human ES cells by Vijayaragavan et
al. (Vijayaragavan et al., 2009). While our work and Gertow et
al. demonstrate an important role of Wnt signaling in the
inhibition of primitive hematopoiesis, this earlier study suggests
that canonical Wnt signaling can enhance hematopoietic
progenitor expansion. This may be due to the effects of Wnt
signaling on distinct hematopoietic populations. The primitive
CMP we describe here is CD45− (data not shown) and may
represent an early primitive yolk sac hematopoietic program
while the CD45+ cells examined by Vijayaragavan et al. may
represent a later definitive yolk sac program. The generation of
two progenitor populations has been documented in human ES
cell differentiation cultures (Vodyanik et al., 2006) and two
populations also arise from the mouse yolk sac during normal
embryogenesis (review in (McGrath and Palis, 2005)). The
differential requirement of Wnt signaling in these two programs
will be an important future area of research. The use of Wnt or
small molecule Wnt agonists to deplete cultures of primitive
CMPsmay represent a powerful tool for the purification ofmore
mature hematopoietic precursors and repopulating hematopoi-
etic stem cells from human ES cell differentiation cultures.
In summary, we demonstrate that the first hematopoietic
progenitor derived from human PSCs has tri-lineage poten-
tial, which we term the primitive CMP. We established a
novel serum-free/stroma free differentiation system for the
generation of large numbers of a homogeneous population of
CMPs that can be isolated by harvesting the supernatant of the
differentiation cultures. These primitive CMPs can be cryo-
preserved, enabling the storage of large numbers of progen-
itors for easy access to use in downstream applications. Lastly,we establish the negative impact of canonical Wnt signaling
in CMP generation and/or survival as well in CMP-derived
megakaryocytes and erythroid cells. This system repre-
sents a powerful and flexible model to study early human
hematopoiesis in vitro.Appendix A. Supplementary data
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2013.12.003.References
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